Editorial Commentary
Circulating tumor DNA (ctDNA)—the next generation biomarker in non-small cell lung cancer patients treated with immunotherapy?
Translational Lung Cancer Research
2024;
13
(9)
:2103-2105
.
(30 September 2024)
Original Article
Utility of atezolizumab plus bevacizumab, carboplatin, and paclitaxel combination for the treatment of advanced non-squamous non-small cell lung cancer patients with malignant pleural effusion
Translational Lung Cancer Research
2024;
13
(9)
:2106-2115
.
(30 September 2024)
TFAP2A-activated ITGB4 promotes lung adenocarcinoma progression and inhibits CD4+/CD8+ T-cell infiltrations by targeting NF-κB signaling pathway
Translational Lung Cancer Research
2024;
13
(9)
:2116-2138
.
(30 September 2024)
IL-1 receptor-associated kinase 3 (IRAK3) in lung adenocarcinoma predicts prognosis and immunotherapy resistance: involvement of multiple inflammation-related pathways
Translational Lung Cancer Research
2024;
13
(9)
:2139-2161
.
(30 September 2024)
Ten-year survival outcomes of video-assisted thoracic surgery vs. open major lung resection for stage I–III non-small cell lung cancer: a large cohort study in China
Translational Lung Cancer Research
2024;
13
(9)
:2162-2174
.
(30 September 2024)
Diagnostic efficacy of cryobiopsy for peripheral pulmonary lesions with ground-glass opacity: a propensity score-matched analysis
Translational Lung Cancer Research
2024;
13
(9)
:2175-2186
.
(30 September 2024)
Incidence, prevalence, and survival of lung cancer in the United Kingdom from 2000–2021: a population-based cohort study
Translational Lung Cancer Research
2024;
13
(9)
:2187-2201
.
(30 September 2024)
Trends in the prescription of immune checkpoint inhibitors for non-small cell lung cancer in the Netherlands from 2016 to 2020, a national cancer registry analysis
Translational Lung Cancer Research
2024;
13
(9)
:2202-2211
.
(30 September 2024)
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
Translational Lung Cancer Research
2024;
13
(9)
:2212-2221
.
(30 September 2024)
Molecular subtypes and prognostic factors of lung large cell neuroendocrine carcinoma
Translational Lung Cancer Research
2024;
13
(9)
:2222-2235
.
(30 September 2024)
Lymph nodes rather than pleural metabolic activity in 18F-FDG PET/CT correlates with malignant pleural effusion recurrence in advanced non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(9)
:2236-2253
.
(30 September 2024)
Establishment of a survival predictive model for patients with two synchronous multiple primary lung cancers: a multicenter cohort analysis
Translational Lung Cancer Research
2024;
13
(9)
:2254-2268
.
(30 September 2024)
Establishing a predictive model for tumor mutation burden status based on 18F-FDG PET/CT and clinical features of non-small cell lung cancer patients
Translational Lung Cancer Research
2024;
13
(9)
:2269-2281
.
(30 September 2024)
Serum tumor markers and outcomes in lung cancer patients with brain metastases: a retrospective longitudinal cohort study
Translational Lung Cancer Research
2024;
13
(9)
:2282-2295
.
(30 September 2024)
Tremelimumab and durvalumab with chemotherapy in first-line treatment for metastatic non-small cell lung cancer: a US-based cost-effectiveness analysis
Translational Lung Cancer Research
2024;
13
(9)
:2296-2306
.
(30 September 2024)
TRIM27 revealing by tumor educated platelet RNA-sequencing, as a potential biomarker for malignant ground-glass opacities diagnosis mediates glycolysis of non-small cell lung cancer cells partially through HOXM1
Translational Lung Cancer Research
2024;
13
(9)
:2307-2325
.
(30 September 2024)
Prognostic value of circulating proteins at diagnosis among patients with lung cancer: a comprehensive analysis by smoking status
Translational Lung Cancer Research
2024;
13
(9)
:2326-2339
.
(30 September 2024)
Establishment of lung cancer cell lines and tumorigenesis in mice from malignant pleural effusion in patients with lung cancer
Translational Lung Cancer Research
2024;
13
(9)
:2340-2351
.
(30 September 2024)
Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma
Translational Lung Cancer Research
2024;
13
(9)
:2352-2372
.
(30 September 2024)
A multi-level investigation of the genetic relationship between gastroesophageal reflux disease and lung cancer
Translational Lung Cancer Research
2024;
13
(9)
:2373-2387
.
(30 September 2024)
Association between fruit intake and non-small cell lung cancer: a Mendelian randomization study
Translational Lung Cancer Research
2024;
13
(9)
:2388-2394
.
(30 September 2024)
Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescence
Translational Lung Cancer Research
2024;
13
(9)
:2395-2410
.
(30 September 2024)
Effect of laterality on the postoperative survival of non-small cell lung cancer patients undergoing pneumonectomy
Translational Lung Cancer Research
2024;
13
(9)
:2411-2423
.
(30 September 2024)
Histopathologic pattern and molecular risk stratification are associated with prognosis in patients with stage IB lung adenocarcinoma
Translational Lung Cancer Research
2024;
13
(9)
:2424-2434
.
(30 September 2024)
EGFR mutations in patients with lung adenocarcinoma and malignant pleural effusion: a propensity score-matched analysis of a single-center database
Translational Lung Cancer Research
2024;
13
(9)
:2435-2447
.
(30 September 2024)
Case Report
Double immune checkpoint inhibitor therapy for unresectable pleural mesothelioma rarely induces hyperprogressive disease: a case report
Translational Lung Cancer Research
2024;
13
(9)
:2448-2452
.
(30 September 2024)
ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination—case report
Translational Lung Cancer Research
2024;
13
(9)
:2453-2462
.
(30 September 2024)
Images in Clinical Medicine
Squamous-cell carcinoma of the recipient’s explanted lung
Translational Lung Cancer Research
2024;
13
(9)
:2463-2465
.
(30 September 2024)
